Cabergoline .5 mg/1
Cabergoline · TABLET · Strides Pharma Science Limited
No Recall History
Plain English
Cabergoline is a tablet containing cabergoline at .5 mg/1, taken oral. Manufactured by Strides Pharma Science Limited.
Key Facts
- Brand Name
- Cabergoline
- Generic Name
- Cabergoline
- NDC Code (Product)
64380-202- Manufacturer
- Strides Pharma Science Limited
- Strength
- .5 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA076310
- Drug Class
- Ergot Derivative [EPC]
- Marketing Start
- 02/27/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective395 reports
off label use370 reports
headache325 reports
fatigue280 reports
nausea277 reports
dizziness225 reports
malaise212 reports
pain198 reports
diarrhoea178 reports
condition aggravated171 reports
Frequently Asked Questions
What is Cabergoline used for?
Cabergoline contains Cabergoline. It is a tablet taken oral. Consult your doctor for specific uses.
Is Cabergoline a controlled substance?
Cabergoline is not classified as a controlled substance by the DEA.
What is the generic name for Cabergoline?
The generic name for Cabergoline is Cabergoline. There are 1 other brand versions of Cabergoline.
What is the NDC code for Cabergoline .5 mg/1?
The NDC (National Drug Code) for Cabergoline .5 mg/1 is 64380-202, listed by Strides Pharma Science Limited.